Evidence map›Paper›PMID 21768539›Full record

ArticleCirculation2011

Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca²⁺release leading to catecholaminergic polymorphic ventricular tachycardia.

Takeshi Suetomi, Masafumi Yano, Hitoshi Uchinoumi, Masakazu Fukuda, Akihiro Hino, Makoto Ono, Xiaojuan Xu, Hiroki Tateishi, Shinichi Okuda, Masahiro Doi and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. A perspective on the future of heart failure research.Journal of molecular and cellular cardiology plus · 2026
    Article
  5. Review
  6. Increased Intermembrane Space [CaCirculation research · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. De novo mutations in childhood cases of sudden unexplained death that disrupt intracellular CaProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Takeshi SuetomiDepartment of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate School of Medicine, Yamaguchi, 755-8505, Japan.
Masafumi Yano
Hitoshi Uchinoumi
Masakazu Fukuda
Akihiro Hino
Makoto Ono
Xiaojuan Xu
Hiroki Tateishi
Shinichi Okuda
Masahiro Doi
Shigeki Kobayashi
Yasuhiro Ikeda
Takeshi Yamamoto
Noriaki Ikemoto
Masunori Matsuzaki
Boston Biomedical Research Institute · US

Funding

Regulation of Normal and Diseased Cardiac Ca2+ ChannelsR01HL072841 · NHLBI · BOSTON BIOMEDICAL RESEARCH INSTITUTE · PI IKEMOTO, NORIAKI · 2003 to 2011
$3.5M
NHLBI NIH HHS R01 HL072841
6 · The paper itself

Abstract

backgroundThe molecular mechanism by which catecholaminergic polymorphic ventricular tachycardia is induced by single amino acid mutations within the cardiac ryanodine receptor (RyR2) remains elusive. In the present study, we investigated mutation-induced conformational defects of RyR2 using a knockin mouse model expressing the human catecholaminergic polymorphic ventricular tachycardia-associated RyR2 mutant (S2246L; serine to leucine mutation at the residue 2246). METHODS AND

resultsAll knockin mice we examined produced ventricular tachycardia after exercise on a treadmill. cAMP-dependent increase in the frequency of Ca²⁺ sparks was more pronounced in saponin-permeabilized knockin cardiomyocytes than in wild-type cardiomyocytes. Site-directed fluorescent labeling and quartz microbalance assays of the specific binding of DP2246 (a peptide corresponding to the 2232 to 2266 region: the 2246 domain) showed that DP2246 binds with the K201-binding sequence of RyR2 (1741 to 2270). Introduction of S2246L mutation into the DP2246 increased the affinity of peptide binding. Fluorescence quench assays of interdomain interactions within RyR2 showed that tight interaction of the 2246 domain/K201-binding domain is coupled with domain unzipping of the N-terminal (1 to 600)/central (2000 to 2500) domain pair in an allosteric manner. Dantrolene corrected the mutation-caused domain unzipping of the domain switch and stopped the exercise-induced ventricular tachycardia.

conclusionsThe catecholaminergic polymorphic ventricular tachycardia-linked mutation of RyR2, S2246L, causes an abnormally tight local subdomain-subdomain interaction within the central domain involving the mutation site, which induces defective interaction between the N-terminal and central domains. This results in an erroneous activation of Ca²⁺ channel in a diastolic state reflecting on the increased Ca²⁺ spark frequency, which then leads to lethal arrhythmia.

Indexed as

Mutation, MissensePoint MutationAllosteric SiteAmino Acid SequenceAmino Acid SubstitutionAnimalsCalciumDantroleneDiastoleEpinephrineGene Knock-In TechniquesHumansIon Channel GatingMiceMice, TransgenicModels, CardiovascularCalciumDantroleneEpinephrineMuscle Relaxants, CentralPeptide FragmentsRecombinant Fusion ProteinsRyanodine Receptor Calcium Release Channel

Identifiers

PMID21768539
PMCPMC3153588
OpenAlexW2050501047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.